Bicycle Partners With Biogen Spinout Against Rare Blood Disorders

 
• By Lucie Ellis-Taitt

Bicycle Therapeutics and Biogen spinoff Bioverativ have teamed up to develop novel treatments for hemophilia and sickle cell disease under a multi-million-dollar discovery and development agreement.

Sickle cell anemia, 3D illustration showing blood vessel with normal and deformated crescent-like red blood cells
Bicycle and Bioverativ strike discovery & development deal for blood disorder drugs

More from Deals

More from Business